MENU
Repare Therapeutics (RPTX) Ownership - Who owns Repare Therapeutics?
Profile
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
139.65M
P/E Ratio
N/A
Total Cash
208.12M
Projected Growth
N/A
Total Debt
2.18M
Revenue
68.68M
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash/Share
4.90
Total Debt/Equity
N/A
Revenue/Share
1.63 USD as % of share price
Fundamentals
RPTX
Capitalization
140M
P/E Ratio
N/A
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash
208M
Total Cash/Share
4.90
Total Debt
2.18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.63%
Revenue
68.7M
ROE
N/A
Book Value
204M
P/B Ratio
0.69
Cash Flow
N/A
Earnings
-1.63
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
486M
Current Ratio
7.27
Current Revenue Per Employee
5994.41
Dividends Per Share - Security
N/A
EBITDA
-93.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-25.52
Shares Held By Institutions
116M
Shares Outstanding - Current
42.4M
Total Liabilities
31.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-54.932
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com